Ocugen (OCGN) Operating Margin (2014 - 2026)
Ocugen (OCGN) reported Operating Margin of 1163.67% for Q1 2026, down 18453.0% on a YoY basis from N/an in Q1 2025, and down 113.21% quarter-over-quarter from 8805.7% in Q4 2025.
Ocugen (OCGN) Operating Margin (2014 - 2026) Analysis & Trends
Ocugen has reported Operating Margin for 7 years, with the latest figure at 1163.67% in Q1 2026.
- For the quarter ending Q1 2026, Operating Margin fell 18453.0% year-over-year to 1163.67%; the trailing twelve-month figure through Mar 2026 stood at 1483.85% (down 22242.0% YoY), and the FY2025 full-year result was 1425.7%, down 7534.0% from the prior year.
- Operating Margin for Q1 2026 stood at 1163.67%, down from 8805.7% in the prior quarter.
- The five-year high for Operating Margin was 8805.7% in Q4 2025, with the low at 5388.41% in Q3 2022.
- Historically, Operating Margin has averaged 1539.43% across 5 years, with a median of 1204.73% in 2024.
- Annual changes were most pronounced in 2023 — Operating Margin tumbled 149809 bps — and 2025, when it surged 1061722 bps.
- Ocugen's Operating Margin stood at 2657.0% in 2022, then surged by 69 bps to 817.96% in 2023, then plunged by 121 bps to 1811.52% in 2024, then soared by 586 bps to 8805.7% in 2025, then sank by 113 bps to 1163.67% in 2026.
- The last three Operating Margin figures came in at 1163.67% (Q1 2026), 8805.7% (Q4 2025), and 1005.99% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -6.43% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 38.10% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Ocugen | 411.07 Mn | 411.07 Mn | - | -1,163.67% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,163.67% |
| Dec 31, 2025 | 8,805.70% |
| Sep 30, 2025 | -1,005.99% |
| Jun 30, 2025 | -1,004.73% |
| Mar 31, 2025 | -979.14% |
| Dec 31, 2024 | -1,811.52% |
| Sep 30, 2024 | -1,166.55% |
| Jun 30, 2024 | -1,353.99% |
| Mar 31, 2024 | -1,204.73% |
| Dec 31, 2023 | -817.96% |
| Sep 30, 2023 | -336.06% |
| Jun 30, 2023 | -4,853.61% |
| Mar 31, 2023 | -4,071.11% |
| Dec 31, 2022 | -2,657.00% |
| Sep 30, 2022 | -5,388.41% |
| Jun 30, 2022 | -3,355.52% |
| Mar 31, 2022 | -3,806.00% |
| Jun 30, 2020 | -7,827.91% |
| Sep 30, 2014 | -2.30% |